The USFDA has approved Lupin’s Abbreviated New Drug Application (ANDA) for Amlodipine Besylate Tablets, 2.5 mg (base), 5 mg (base) and 10 mg (base). Saleable deliveries of Amlodipine Besylate Tablets will begin soon.

The company’s Amlodipine Besylate Tablets are the AB-rated generic correspondent of Pfizer’s Norvasc’ pills, which is long-acting calcium channel blocker suggested for treating hypertension.

Based on IMS Health sales information, the brand product had annual sales of around USD 2.7 billion for the twelve months ended December 2006,.

Shares of the company were up Rs 10.20, or 1.43%, at Rs 724.05. Total volume of shares traded at the BSE was 30,704.